Docs, Pharma Under Increased Scrutiny

Wall Street Journal, New York Times , Wednesday, December 31, 2008 11 AM
  • Comment
  • Recommend
Subscribe to Around the Net In Brand Marketing

Tags

Dr. Joseph Biederman, who has been a prominent backer of childhood use of Johnson & Johnson's antipsychotic drug Risperdal, will discontinue his participation in several industry-funded clinical trials at Massachusetts General Hospital pending the results of the hospital's inquiry into his potential conflicts of interest and disclosure obligations, Jennifer Levitz reports. A hospital spokeswoman says the studies will continue under another doctor.

Massachusetts General has said it was concerned that an institute that Biederman and J&J worked together to create at the hospital was used to promote Risperdal's use in children, rather than for scientific or educational purposes. In a letter published this month in the Journal, Biederman maintained that J&J's interests didn't interfere with the institute's work.

The Times' Natasha Singer reminds us that come the New Year, doctors will have to pay for their own Pilots and Sharpies, and drink coffee out of mugs that don't promote the likes of Viagra. All those gimcracks and gewgaws that doctors have been getting from the pharmaceutical industry are verboten under voluntary guidelines drawn up by Pharmaceutical Research and Manufacturers of America.

While the industry maintains that the giveaways never influenced a doctor to do anything, critics maintain that drug marketers still wield too much influence. "The guidelines, for example, still permit drug makers to underwrite free lunches for doctors and their staffs or to sponsor dinners for doctors at restaurants, as long as the meals are accompanied by educational presentations," Singer writes in a front-page piece.
Read the whole story at Wall Street Journal, New York Times »
  • Comment
  • Recommend

Be the first to comment on "Docs, Pharma Under Increased Scrutiny "

Leave a Comment

Sign in to leave a comment. Don't have an account? Join Now

Recent Around the Net In Brand Marketing Articles

  • Are Facebook's 'Likes' Free Speech?  
    In a court room in Virginia, Facebook's lawyers are busy arguing that the social network's “Like” ...
  • The Next Martha Stewart  
    Brit Morin may be the next -- or at the least a digital -- Martha Stewart. ...
  • Kroger Defends Ditching Double Coupons  
    Kroger's CFO said the grocery chain's double coupons in several markets was “a very expensive reward ...
  • Fiat May Move HQ To U.S.  
    With Fiat SpA hoping to wrap up its takeover of Chrysler LLC sometime this year, the ...
  • Mozilla Delays Blocking Cookies  
    Mozilla has postponed activating the third-party blocking feature on its latest browser, Firefox 22, according to ...
  • Heineken Aligns Web And TV  
    Heineken is looking to make more original content for online channels and more long-form digital programming. ...
  • Craft Beer Grows   
    Consumers have increased beer consumption, and craft beers have benefited. According to Chicago-based research firm Mintel, ...
  • In Peru: Billboard Ads You Can Drink  
    A Clear Channel billboard in Peru, the first to extract drinking water from air has produced ...
  • Netflix Says It Won't Sell Ads  
    Netflix says it won’t be selling ads for its streaming site. Netflix executive David Wells, speaking ...
  • New App Lets You 'Buycott' Frankenseed Maker   
    Big surprise: the Supreme Court comes down on the independent farmer. Consumer sentiment about Monsanto isn't top ...
>> Around the Net In Brand Marketing Archives